Glaxo Group Limited v Avexa Limited [Sec=Unclassified]

Link copied
Case Copied 22 min read

TRADE MARKS ACT 1995



DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Opposition by Glaxo Group Limited to registration of trade mark application 1088656(1, 5, 42, 44) - AVEXA - filed in the name of Avexa Limited.

Delegate: Alison Windsor
Representation: Opponent:  Fiona Symons of Davies Collison Cave, patent and trade mark attorneys
Applicant:  Dr Warwick Rothnie of counsel instructed by Ellis Technology Lawyers
Decision: 2009 ATMO 84
S52 opposition: ss42(b), 44, 59 and 60 – no grounds established -  - opposition fails – costs awarded against opponent

Background

  1. Avexa Limited (“the applicant”) filed an application to register a trade mark, current details of which are shown below:

    Trade mark number:             1088656
    Filing date:  2 December 2005

    Goods/service specifications:           Class 1:  Chemicals for use in science, research and industry; chemicals and chemical reagents for use in the manufacture of pharmaceuticals

    Class 5:Pharmaceutical preparations and substances including preparations for healthcare, chemicals and chemical preparations and substances used for medicinal and pharmaceutical purposes and in medicines

    Class 42:Scientific and technological services and research and design relating thereto; industrial analysis and research services

    Class 44:Medical services, healthcare services; advisory services relating to healthcare

    Trade Mark:  AVEXA

  2. The application was examined as required by section 31 of the Trade Marks Act 1995 (“the Act”) and on 8 March 2007 was advertised in the Australian Official Journal of Trade Marks as accepted for possible registration.

  3. On 11 May 2007 Glaxo Group Limited (“the opponent”) filed a notice of opposition (“the notice”) in the broadest possible terms.  Evidence in support, in answer and in reply were filed in due course.  The opponent then requested a hearing.

  4. I heard the opposition in Melbourne on 24 July 2009 in my capacity as a delegate of the Registrar of Trade Marks.  At the hearing, the applicant was represented by Dr Warwick Rothnie of counsel, instructed by Ellis Technology Lawyers.  The opponent was represented by Fiona Symons of Davies Collison Cave, patent and trade mark attorneys.

    Grounds of opposition and onus

  5. At the hearing the opponent pursued only the following grounds: 

    ·   Paragraph 42(b) – use contrary to law

    · Section 44 – identical etc trade mark, specifically in relation to registration no. 1010296 – KIVEXA – for pharmaceutical preparations and substances in class 5

    · Section 59 – the applicant does not intend to use or authorise use of the trade mark or assign it to a body corporate

    · Section 60 – trade mark similar to one with a reputation within Australia.

  6. As none of the other grounds nominated on the notice were referred to, I find that none of them have been established.

  7. The onus is on the opponent to establish one or more of the four grounds it pursued.  The standard to be applied in deciding the matter is that of “the balance of probabilities”.[1]  The facts relevant to the opposition are to be judged as at the priority date.

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Glaxo Group Limited v Avexa Limited [Sec=Unclassified] and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2009] ATMO 84
Decision Date

CaseChat Overview and Summary

This matter concerned an opposition by Glaxo Group Limited (the opponent) to the registration of the trade mark "AVEXA" by Avexa Limited (the applicant) in relation to goods in Class 5. The opposition was brought on several grounds, including that the applicant did not intend to use the trade mark in respect of the goods claimed, pursuant to section 59 of the *Trade Marks Act 1995* (Cth).

The primary legal issue before the Hearing Officer was whether the opponent had established a prima facie case that the applicant lacked the requisite intention to use the trade mark "AVEXA" in relation to Class 5 goods at the time of filing the application. The opponent also raised issues under sections 44, 42, and 60 of the Act, but the Hearing Officer indicated that the determination of the section 59 ground would likely impact the consideration of these other grounds.

The Hearing Officer considered evidence from the opponent suggesting that at the time of filing, the applicant's direction had not been fully scoped and that the mark "AVEXA" would not be the name of a new product, nor would it be used for future pharmaceutical products. The opponent also pointed to the applicant's failure to apply for TGA listing for the name and its lack of evidence of use. However, the Hearing Officer found that the opponent had not established any ground of opposition. The Hearing Officer specifically noted that the existence of a previously registered trade mark, which the opponent had not opposed, was not taken into account in the decision.

The opposition was dismissed, and the application for the trade mark "AVEXA" was permitted to proceed to registration one month from the date of the decision, subject to any notification of an appeal. Costs were awarded against the opponent.

Orders

Orders of the court

Background

Background to the litigation

Evidence

Evidence Before The Court

The Yeo declaration provides a different view of the matter of “medication misadventure”. Professor Yeo states that he agrees with Mr Marty that medication misadventures are common, but disagrees with the prominence given to errors arising from similarly named drugs. Specifically, he disagrees with the assertion that such an error is likely to occur when an individual drug has a similar name to a house mark. Evidence in Reply The Symons declaration contains examples of packaging from a range of pharmaceutical products, all of which include both a “house mark” and a product name on the package.Discussion and reasons The bulk of the opponent’s submissions at the hearing were in respect of the grounds nominated under sections 44 and 59 of the Act. As the result of my decision in respect of either of these two sections is likely to affect the operation of sections 42 and 60, it is appropriate that I deal with these sections first. Section 59 – Applicant not intending to use trade mark This is a challenging ground for the opponent in that it needs to establish a prima facie case that the applicant, despite the intention said to be evidenced by its filing of the application,[2] did not intend to use its trade mark in respect of the goods and services claimed. [2] Aston v Harlee Manufacturing Co (1960) 103 CLR 391 The opponent submitted that at the date of filing the applicant had no intention to use its trade mark in respect of the goods claimed in class 5. Support for this submission, Ms Symons said, was found at paragraph 5 of the Chick declaration which states: … at that time [2 December 2005], Avexa Limited had only recently been listed and the direction of the company had not been fully scoped. Therefore, Avexa Limited applied for the mark AVEXA in the following classes .. . This, Ms Symons said, shows that “the applicant had not formed the requisite ‘resolved or settled’ intention to use the AVEXA trade mark in relation to Class 5 goods.”[3] She provided additional support to this contention in her references to the following paragraphs of the Chick declaration:11. While no name has been selected, I am able to say categorically state [sic] that the mark AVEXA will not be the name of the new product.12. I am also able to say that Avexa does not intend to use the mark AVEXA for any pharmaceutical products (’Drugs’) that Avexa will market in the future.[3] Ducker’s Trade Mark (1928) 45 RPC 397; Lomas v Winton Shire Council [2002] FACFC 413 Ms Symons also considered that the applicant’s failure to apply for TGA listing for the name AVEXA was indicative of its lack of intention to use the name in relation to Class 5 goods, as was its failure to provide any examples of the trade mark in use. She suggested the lack of intention to use demonstrated by the information she had provided allowed for either refusal of the registration as a whole, or as an alternative, deletion of class 5 from the application, allowing it to proceed to registration in the remaining classes.

Decision

Reasons for decision

The opponent submitted that the existence of this registered trade mark should not provide a precedent in respect of the decision on the opposed trade mark. The comments made suggest that the opponent’s failure to oppose the now registered trade mark were the result of an oversight at the time. For what little solace it provides, I make it clear that the existence of the already registered trade mark has not figured at all in my considerations of the applicant’s opposed trade mark. Decision The opponent has not established any ground of opposition, and is therefore unsuccessful in this action. Application 1088656 may proceed to registration one month from the date of this decision. If the Registrar is notified of an appeal from this decision before that time, the application will not proceed to registration until such time as the appeal has been discontinued or registration is otherwise ordered by the court. Costs Both parties requested their costs in the event of success. Costs usually follow the event. I therefore award costs against the opponent according to the official scale.Alison WindsorHearing OfficerTrade Marks and Designs Hearings28 October 2009

Ratio Decidendi

Legal Principle Established